Clearmind Medicine Inc. (CMND) stock
CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$3.45−0.73 (-17.52%)
Close on Nov 17, 2026Market cap $545.36KP/E –Yield –
Clearmind Medicine market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Clearmind Medicine's market cap was $629.11K on Nov 11, 2026, against $38.34M a year earlier. Over the last 5 years it ranged from $629.11K to $1.40B, with a median of $41.31M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $629.11K | -94.4% |
| 2025 | Dec 31, 2025 | $11.22M | -49.8% |
| 2024 | Dec 31, 2024 | $22.35M | +129.5% |
| 2023 | Dec 29, 2023 | $9.74M | -97.1% |
| 2022 | Dec 30, 2022 | $333.73M | -49.9% |
| 2021 | Dec 31, 2021 | $665.50M | – |
See a number that looks wrong?